TYRX (Acquired) is Profiled in this Database

Updated At 28 Feb, 2012

Start Free 7 Day Trial Now
Partial description of this company
Innovative, implantable, combination drug+device products that utilize novel biomaterials. TYRX\'s first commercially available products include the AIGISRx(R) Antibacterial Envelope & Flat Sheet technologies, designed to reduce surgical-site infections associated with Cardiac Implantable Electronic Devices (CIEDs).

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of TYRX (Acquired) plus 5030 other startups.

Start Free 7 Day Trial Now

Learn More About TYRX (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients